Results from the first U.S. clinical trial investigating the benefit of using a patient's own (autologous) selected adult stem cells, called CD34+ cells, to treat coronary artery disease are promising.
New solar cells don't need direct sunlight to operate and use a patented range of dyes that can be impregnated in roofs, window glass and eventually even clothing to produce power.
K. Li, C. Grauschopf, R. Hedrich, I. Dreyer, и K. Konrad. New Phytol, 241 (4):
1525-1542(2024)Li, Kunkun
Grauschopf, Christina
Hedrich, Rainer
Dreyer, Ingo
Konrad, Kai R
eng
1220504/Agencia Nacional de Investigacion y Desarrollo/
ATE220043/Agencia Nacional de Investigacion y Desarrollo/
KO3657/2-3/Deutsche Forschungsgemeinschaft/
201706320320/Chinese Scholarship Council/
England
2023/11/29
New Phytol. 2024 Feb;241(4):1525-1542. doi: 10.1111/nph.19436. Epub 2023 Nov 28..